Delivery Order SPE2DB24D2101-SPE2DB26FKFAV
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Pantoprazole Sodium Delayed-Release 40 mg tablets in a quantity of 1,000 units, with a ceiling value of $2,535.19. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for ultimate completion on September 23, 2025, and will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Pantoprazole Sodium Delayed-Release 40 mg tablets in a quantity of 1,000 units, with a ceiling value of $2,058.66. This competitive award, which utilizes firm fixed price pricing, represents a non-set-aside contract and is scheduled for completion by August 29, 2025. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,119.58 to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in quantities of 1,000 units. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract is scheduled for ultimate completion on September 17, 2025, with performance occurring at the vendor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a quantity of 1,000 units, with a ceiling value of $3,309.50. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a quantity of 1,000 units, with a contract value of $1,013.16. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively awarded. The order is set for ultimate completion on August 1, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,786.98 to AmerisourceBergen Drug Corp for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in quantities of 1,000 units. This is a firm fixed-price contract with no set-aside designation, reflecting a competitively awarded transaction. The delivery order was executed on October 17, 2025, with an ultimate completion date of October 20, 2025, and will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a quantity of 1,000 units, with a ceiling value of $5,258.71. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 15, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a quantity of 1,000 units, with a contract ceiling value of $3,894.81. This competitively awarded, firm fixed-price delivery order is not set-aside and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 10, 2025. The order represents...
- The Defense Logistics Agency awarded a $3,604.57 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of 1,000 tablets of Pantoprazole Sodium delayed-release 40 mg. This competitive delivery order, which is set to be completed by September 18, 2025, represents a firm fixed-price transaction issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX, valued at $999,999,999.00 through December 2026). The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 8, 2025, for the supply of Pantoprazole Sodium Delayed-Release 40 mg tablets (1,000 count) at a firm fixed price of $1,094.58. This is a non-set-aside, competitively awarded contract with an ultimate completion date of July 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB26FKFAVDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a quantity of 1,000 units, valued at $2,108.69. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under open competition. The contract is set to be completed by October 22, 2025, with performance occurring at the vendor's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive portfolio under its DLA prime vendor contract encompasses a wide range of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This specific delivery order for pantoprazole, a gastric acid suppressant commonly used in military and federal healthcare settings, exemplifies the company's role in fulfilling routine pharmaceutical supply needs across the Department of Defense medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 10/21/25 |